Oral Ketamine For At Home Treatment

FOR IMMEDIATE RELEASE

A growing number of psychiatric practices in South Florida are now offering oral ketamine as an at-home treatment option for patients with treatment-resistant depression, anxiety, and certain chronic pain conditions. This development represents a significant shift in the accessibility of ketamine-based therapies, which have traditionally been limited to in-clinic IV infusions or the FDA-approved nasal spray esketamine (Spravato).

How Oral Ketamine Works

Oral ketamine is prescribed as sublingual tablets or troches (lozenges) that dissolve under the tongue, allowing the medication to be absorbed through the oral mucosa. While the bioavailability is lower than IV administration — typically 20-30 percent compared to nearly 100 percent for IV — the convenience and lower cost of at-home treatment make it an attractive option for many patients.

Patients receive their prescription after an initial in-person evaluation and are given detailed instructions for safe administration at home. Sessions typically involve taking the medication in a calm, comfortable environment with a sober companion present, lying down for 45-60 minutes, and resting until effects fully resolve.

Safety Considerations

While at-home ketamine treatment offers greater accessibility, it also requires careful patient selection and monitoring. Physicians prescribing oral ketamine conduct thorough psychiatric and medical evaluations, screen for contraindications, and maintain regular follow-up appointments to assess treatment response and watch for potential issues.

Patients with a history of substance abuse, uncontrolled hypertension, or certain psychiatric conditions may not be appropriate candidates for at-home treatment and may be better served by supervised in-clinic sessions.

The Evolving Landscape

The expansion of at-home ketamine treatment reflects a broader trend toward making innovative psychiatric treatments more accessible. As telehealth capabilities improve and clinical evidence accumulates, the model of supervised at-home treatment is likely to become increasingly common for appropriate patients.

Patients interested in oral ketamine should consult with a qualified psychiatric provider to determine whether this treatment approach is appropriate for their specific situation.